CINCOR PHARMA, INC.

(CINC)
  Rapport
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op CINCOR PHARMA, INC.
24/06CINCOR PHARMA, INC.(NASDAQGM : CINC) dropped from Russell Microcap Growth Index
24/06CINCOR PHARMA, INC.(NASDAQGM : CINC) dropped from Russell 3000E Growth Index
24/06CINCOR PHARMA, INC.(NASDAQGM : CINC) dropped from Russell 3000 Growth Index
24/06CINCOR PHARMA, INC.(NASDAQGM : CINC) dropped from Russell Small Cap Comp Growth Index
24/06CINCOR PHARMA, INC.(NASDAQGM : CINC) dropped from Russell 2000 Growth Index
24/06CINCOR PHARMA, INC.(NASDAQGM : CINC) dropped from Russell 2500 Growth Index
20/06CINCOR PHARMA, INC.(NASDAQGM : CINC) added to S&P Global BMI Index
01/06CinCor Pharma Doses First Patient in Chronic Kidney Disease Treatment Phase 2 Trial; Sh..
01/06CinCor Pharma Doses First Patient in Phase 2 FigHTN-CKD Trial Evaluating the Selective ..
01/06CinCor Pharma, Inc Doses First Patient in Phase 2 FigHTN-CKD Trial Evaluating the Selec..
31/05CinCor Pharma to Present at the Jefferies Healthcare Conference
31/05CinCor Pharma to Present at the Jefferies Healthcare Conference
17/05CinCor Pharma to Present at Upcoming Investor Conferences
17/05CinCor Pharma to Present at Upcoming Investor Conferences
13/05CINCOR PHARMA : Corporate Presentation – May 2022
10/05CINCOR PHARMA, INC. Management's Discussion and Analysis of Financial Condition and Re..
10/05CinCor Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
10/05CinCor Reports First Quarter Financial Results and Provides Corporate Update
10/05CinCor Reports First Quarter Financial Results and Provides Corporate Update
06/05Factbox-New U.S. stock listings fail to impress in turbulent 2022
19/04CinCor Pharma to Participate in Jefferies Biotech on the Bay Summit
22/03CINCOR PHARMA, INC. Management's Discussion and Analysis of Financial Condition and Re..
22/03CinCor Pharma's Q4 Loss Widens
22/03CINCOR PHARMA : Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides C..
22/03CinCor Pharma, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended..
22/03CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corpora..
22/03CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corpora..
21/03CINCOR PHARMA, INC.(NASDAQGM : CINC) added to S&P TMI Index
17/03CinCor Pharma to be Added to Russell 2000ģ and Russell 3000ģ Indexes
15/03CinCor Pharma to Report Fourth Quarter and Full Year 2021 Financial Results and Host Co..
03/03CinCor Pharma to Present at the 32nd Annual Oppenheimer Healthcare Conference
08/02Mydecine Innovations Group (MYCOF) Submits Pre-Investigational New Drug Briefing Packag..
28/01CINCOR PHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
13/01INSIDER BUY : CinCor Pharma
13/01INSIDER BUY : CinCor Pharma
13/01CinCor Pharma Appoints June Lee to Its Board of Directors
13/01CinCor Pharma Appoints June Lee to Its Board of Directors
11/01CINCOR PHARMA, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin..
10/01CINCOR PHARMA, INC.(NASDAQGM : CINC) added to NASDAQ Composite Index
07/01CinCor Pharma Shares Pares Gains After Opening Above IPO Price in Stock Market Debut
07/01CinCor Pharma Prices IPO at $16 Per Share
07/01CinCor Pharma Announces Pricing of Initial Public Offering
06/01CinCor Pharma, Inc. has completed an IPO in the amount of $193.6 million.
2021CinCor Pharma, Inc. has filed an IPO in the amount of $100 million.